1.0Pharma Trendhttps://pharma-trend.com/enBusiness Wirehttps://pharma-trend.com/en/author/business/ONWARD Announces New Board Appointment - Pharma Trendrich600338<blockquote class="wp-embedded-content" data-secret="e9bpxiPf8P"><a href="https://pharma-trend.com/en/onward-announces-new-board-appointment/">ONWARD Announces New Board Appointment</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://pharma-trend.com/en/onward-announces-new-board-appointment/embed/#?secret=e9bpxiPf8P" width="600" height="338" title="“ONWARD Announces New Board Appointment” — Pharma Trend" data-secret="e9bpxiPf8P" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://pharma-trend.com/en/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
Market Access expert Kristina Dziekan appointed as Non-Executive Director EINDHOVEN, the Netherlands & LAUSANNE, Switzerland–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces the appointment of Kristina Dziekan to its Board of Directors. “Kristina strengthens our Board, ... [Read more...]https://mms.businesswire.com/media/20220613005579/en/1484539/21/Mrs._Dzieken.jpg